From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
Open accessThe DOI matches its Crossref record; 685 of the 685 references it cites were found in a registry or an index.
Abstract
Central nervous system disorders drive disability, yet many neuroactive candidates fail because the brain is a hard compartment to dose. Plant-derived molecules spanning polyphenols, alkaloids, terpenoids, and cannabinoids are attractive because their pleiotropic actions can engage oxidative stress, neuroinflammation, and circuit dysfunction. In practice, the blood–brain barrier (BBB) restricts most native phytochemicals through tight-junction selectivity, rapid metabolism, low solubility, and transporter-mediated efflux. Key gaps include poor standardization of exposure metrics, limited human-relevant BBB models, and few head-to-head studies that compare delivery platforms on the same payload and outcome. This review tackles the mismatch between mechanistic promise and reliable brain exposure that stalls translation. The objectives are to link phytochemical liabilities to enabling strategies in nanomedicine, alternative routes, and transporter-targeted prodrugs, and to propose decision-grade endpoints for translation. We synthesize evidence on BBB transport logic, nanocarrier families, targeting ligands, intranasal delivery, focused ultrasound-mediated opening, and prodrug approaches that hijack influx transporters, while foregrounding safety and chemistry, manufacturing, and controls (CMC) constraints. Here we highlight that effective neurotherapeutics emerge when chemistry, carrier, route, and measurement are co-designed rather than optimized in isolation. This framework can guide platform selection, de-risk first in-human studies, and sharpen trial endpoints. More broadly, it offers a transferable playbook for barrier-limited drug development across neurology, psychiatry, and oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, BBB constraints remain a central translational hurdle [126].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 685
Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment
Ramalho, M. J., Sevin, E., Gosselet, F., Lima, J., Coelho, M. A. N., Loureiro, J. A., & Pereira, M. C. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.062 · Cited by 142
Loryan, I., Reichel, A., Feng, B., Bundgaard, C., Shaffer, C., Kalvass, C., Bednarczyk, D., Morrison, D., Lesuisse, D., Hoppe, E., et al. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03246-6 · Cited by 142
Recent advances in human iPSC-derived models of the blood–brain barrier
Workman, M. J., & Svendsen, C. N. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00191-7 · Cited by 140
Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures
Zhu, M., Zhuang, J., Li, Z., Liu, Q., Zhao, R., Gao, Z., Midgley, A. C., Qi, T., Tian, J., Zhang, Z., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01323-4 · Cited by 140
Yang, S., Xing-ming, H., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., & Wu, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050623 · Cited by 140
Akkol, E. K., Çankaya, İ. İ. T., Karatoprak, G. Ş., Çarpar, E., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669638 · Cited by 138
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138
Liu, X., & Meng, H. (2021) · VIEW · doi:10.1002/viw.20200190 · Cited by 137
Central nervous system delivery of molecules across the blood-brain barrier
Gosselet, F., Loiola, R. A., Roig, A., Rosell, A., & Culot, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104952 · Cited by 137
Beltrán-Velasco, A. I., & Clemente‐Suárez, V. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062440 · Cited by 137
Chen, Z.-A., Wu, C. ‐., Wu, S., Huang, C.-Y., Mou, C., Wei, K., Yen, Y., Chien, I.-T., Runa, S., Chen, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08993 · Cited by 136
Ghorai, S. M., Deep, A., Magoo, D., Gupta, C., & Gupta, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071999 · Cited by 136
Chen, Y., Douanne, N., Wu, T.-C., Kaur, I., Tsering, T., Erzingatzian, A., Nadeau, A., Juncker, D., Nerguizian, V., & Burnier, J. V. (2025) · Science Advances · doi:10.1126/sciadv.ads5249 · Cited by 136
Bioavailability of Food Polyphenols: Current State of Knowledge
Williamson, G. (2025) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-060721-023817 · Cited by 135
Unravelling the Potential of Graphene Quantum Dots in Biomedicine and Neuroscience
Perini, G., Palmieri, V., Ciasca, G., Spirito, M. D., & Papi, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103712 · Cited by 134
Lofts, A., Abu-Hijleh, F. A., Rigg, N., Mishra, R. K., & Hoare, T. R. (2022) · CNS Drugs · doi:10.1007/s40263-022-00930-4 · Cited by 133
Sun, T., Samiotaki, G., Wang, S., Acosta, C., Chen, C. C., & Konofagou, E. E. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/23/9079 · Cited by 133
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
Thomsen, M. S., Johnsen, K. B., Kucharz, K., Lauritzen, M., & Moos, T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102237 · Cited by 131
Ranjbar, S., Emamjomeh, A., Sharifi, F., Zarepour, A., Aghaabbasi, K., Dehshahri, A., Sepahvand, A. M., Zarrabi, A., Beyzaei, H., Zahedi, M. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071944 · Cited by 131
Nguyen, T.-T.-L., & Maeng, H.-J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030572 · Cited by 130
Kopeček, J., & Yang, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.020 · Cited by 130
Monge-Fuentes, V., Biolchi Mayer, A., Lima, M. R., Geraldes, L. R., Zanotto, L. N., Moreira, K. G., Martins, O. P., Piva, H. L., Felipe, M. S. S., Amaral, A. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94175-8 · Cited by 129
Villabona-Rueda, A., Erice, C., Pardo, C. A., & Stins, M. F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00405 · Cited by 128
Tissue Engineering 3D Neurovascular Units: A Biomaterials and Bioprinting Perspective
Potjewyd, G., Moxon, S. R., Wang, T., Domingos, M. A. N., & Hooper, N. M. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.01.003 · Cited by 127
Cannabinoids, Blood–Brain Barrier, and Brain Disposition
Calapai, F., Cardia, L., Sorbara, E. E., Navarra, M., Gangemi, S., Calapai, G., & Mannucci, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030265 · Cited by 127
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Pedder, J. H., Sonabend, A. M., Cearns, M. D., Michael, B. D., Zakaria, R., Heimberger, A. B., Jenkinson, M. D., & Dickens, D. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00476-9 · Cited by 127
Liu, S., Jin, X., Ge, Y., Dong, J., Liu, X., Pei, X., Wang, P., Wang, B., Chang, Y., & Yu, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03415-w · Cited by 127
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease
Leta, V., Klingelhoefer, L., Longardner, K., Campagnolo, M., Levent, H. Ç., Aureli, F., Metta, V., Bhidayasiri, R., Chung‐Faye, G., Falup‐Pecurariu, C., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15734 · Cited by 126
Wu, S.-Y., Aurup, C., Sanchez, C. S., Grondin, J., Zheng, W., Kamimura, H., Ferrera, V. P., & Konofagou, E. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25904-9 · Cited by 125
Artificial intelligence in multi-objective drug design
Luukkonen, S., van den Maagdenberg, H. W., Emmerich, M., & van Westen, G. J. P. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102537 · Cited by 125
Carbon Quantum Dots in Biomedical Applications: Advances, Challenges, and Future Prospects
Печникова, Н. А., Domvri, K., Porpodis, Κ., Istomina, M. S., Iaremenko, A. V., & Yaremenko, A. V. (2024) · Aggregate · doi:10.1002/agt2.707 · Cited by 124
Kucharz, K., Kristensen, K., Johnsen, K. B., Lund, M. A., Lønstrup, M., Moos, T., Andresen, T. L., & Lauritzen, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-24323-1 · Cited by 123
Sanadgol, N., Abedi, M., Hashemzaei, M., Kamran, Z., Khalseh, R., Beyer, C., & Voelz, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03528-2 · Cited by 123
Laurindo, L. F., de Carvalho, G. M., de Oliveira Zanuso, B., Figueira, M. E., Direito, R., de Alvares Goulart, R., Buglio, D. S., & Barbalho, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010229 · Cited by 122
Self-citationZhang, Y., Zhai, M., Chen, Z., Han, X., Yu, F., Li, Z., Xie, X., Han, C., Yu, L., Yang, Y., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1344334 · Cited by 122
Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles
Kashapov, R. R., Ibragimova, A. R., Pavlov, R. V., Gabdrakhmanov, D. R., Kashapova, N. E., Burilova, E. A., Zakharova, L. Y., & Sinyashin, O. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137055 · Cited by 122
In vitro hemocompatibility testing of medical devices
Nalezinková, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.07.027 · Cited by 121
Zanos, P., Piantadosi, S. C., Wu, H., Pribut, H. J., Dell, M. J., Can, A., Snodgrass, H. R., Zarate, C. A., Schwarcz, R. M., & Gould, T. D. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225664 · Cited by 121
Tashima, T. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00854 · Cited by 120
Does kynurenic acid act on nicotinic receptors? An assessment of the evidence
Stone, T. W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14907 · Cited by 117
Jiang, T., Qiao, Y., Ruan, W., Zhang, D., Yang, Q., Wang, G., Chen, Q., Zhu, F., Yin, J., Zou, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104779 · Cited by 117
Nanomedicine: controlling nanoparticle clearance for translational success
Zhu, G. H., Gray, A. B. C., & Patra, H. K. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.05.001 · Cited by 117
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Blebea, N. M., Pricopie, A. I., Vlad, R.-A., & Hancu, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084204 · Cited by 117
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs
Clementino, A. R., Pellegrini, G., Banella, S., Colombo, G., Cantù, L., Sonvico, F., & Del Favero, E. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00366 · Cited by 116
Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
Maher, R., Moreno-Borrallo, A., Jindal, D., Mai, B. T., Ruiz‐Hernández, E., & Harkin, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030746 · Cited by 116
Kabir, M. T., Uddin, M. S., Begum, M. M., Thangapandiyan, S., Rahman, M. S., Aleya, L., Mathew, B., Ahmed, M., Barreto, G. E., & Ashraf, G. M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191008103141 · Cited by 116
Pires, P. C., Rodrigues, M., Alves, G., & Santos, A. O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030588 · Cited by 116
Transportation of Single-Domain Antibodies through the Blood–Brain Barrier
Ruiz-López, E., & Schuhmacher, A. J. (2021) · Biomolecules · doi:10.3390/biom11081131 · Cited by 114
Canfield, S. G., Stebbins, M. J., Faubion, M. G., Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0145-6 · Cited by 113
Peterson, B., Weyers, M., Steenekamp, J. H., Steyn, J. D., Gouws, C., & Hamman, J. H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010033 · Cited by 113
Todd, N., Angolano, C., Ferran, C., Devor, A., Borsook, D., & McDannold, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.040 · Cited by 112
Lipid-Based Nanotechnology: Liposome
Jiang, Y., Li, W., Wang, Z., & Lu, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010034 · Cited by 112
Quantification and pharmacokinetics of blood-brain barrier disruption in humans
Zünkeler, B., Carson, R. E., Olson, J., Blasberg, R. G., Devroom, H., Lutz, R. J., Saris, S. C., Wright, D. C., Kammerer, W., Patronas, N. J., et al. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.85.6.1056 · Cited by 111
Liu, L., Zhang, L., Feng, H., Li, S., Liu, M., Zhao, J. H., & Liu, H. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00343 · Cited by 110
Baron, B. M., Harrison, B. L., Miller, F. P., McDonald, I. A., Salituro, F. G., Schmidt, C. J., Sorensen, S. M., White, H. S., & Palfreyman, M. G. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09491-x · Cited by 109
Long-term in vivo biocompatibility of single-walled carbon nanotubes
Galassi, T. V., Antman‐Passig, M., Yaari, Z. A., Jessurun, J., Schwartz, R. E., & Heller, D. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226791 · Cited by 109
Heneka, M. T., Gauthier, S. G., Chandekar, S. A., Hahn-Pedersen, J. H., Bentsen, M. A., & Zetterberg, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02939-9 · Cited by 108
Shi, D., Mi, G., Shen, Y., & Webster, T. J. (2019) · Nanoscale · doi:10.1039/c9nr03931g · Cited by 108
Effect of Particle Size and Surface Charge on Nanoparticles Diffusion in the Brain White Matter
Tian, Y., Gao, L., Zhan, W., & Dini, D. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03222-0 · Cited by 106
Li, X., Huang, L., Liu, G., Fan, W., Li, B., Liu, R., Wang, Z., Fan, Q., Xiao, W., Li, Y., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112365 · Cited by 106
Sheffey, V. V., Siew, E. B., Tanner, E. E. L., & Eniola‐Adefeso, O. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202101536 · Cited by 106
Stanimirovic, D. B., Sandhu, J. K., & Costain, W. J. (2018) · BioDrugs · doi:10.1007/s40259-018-0309-y · Cited by 105
PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia
Santos, S. D., Xavier, M., Leite, D. M., Moreira, D. A., Custódio, B., Torrado, M., Castro, R., Leiro, V., Rodrigues, J., Tomás, H., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.006 · Cited by 105
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route
El-Enin, H. A. A., Elkomy, M. H., Naguib, I. A., Ahmed, M. F. E., Alsaidan, O. A., Alsalahat, I., Ghoneim, M. M., & Eid, H. M. (2022) · Pharmaceuticals · doi:10.3390/ph15030281 · Cited by 104
Mukherjee, S., Baidoo, J., Sampat, S., Mancuso, A., David, L., Cohen, L. S., Zhou, S., & Banerjee, P. (2018) · Molecules · doi:10.3390/molecules23010201 · Cited by 104
Biodistribution of Carbon Nanotubes in Animal Models
Jacobsen, N. R., Möller, P., Clausen, P. A., Saber, A. T., Micheletti, C., Jensen, K. A., Wallin, H., & Vogel, U. B. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12705 · Cited by 103
Moreira, R., Nóbrega, C., de Almeida, L. P., & Mendonça, L. S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02511-7 · Cited by 103
Factors affecting delivery of antiviral drugs to the brain
Strazielle, N., & Ghersi-Egea, J.-F. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.454 · Cited by 102
Guo, Q., Xu, S., Yang, P., Wang, P., Lu, S., Sheng, D., Qian, K., Cao, J., Lu, W., & Zhang, Q. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.039 · Cited by 102
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
Xu, X., Xu, L., Wen, C., Xia, J., Zhang, Y., & Liang, Y. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100760 · Cited by 101
Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles
Wang, L., Quine, S., Frickenstein, A. N., Lee, M., Yang, W., Sheth, V. M., Bourlon, M. D., He, Y., Lyu, S., Garcia‐Contreras, L., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308446 · Cited by 101
Obstacles in Haemocompatibility Testing
van Oeveren, W. (2013) · Scientifica · doi:10.1155/2013/392584 · Cited by 100
Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research
Ailuno, G., Baldassari, S., Lai, F., Florio, T., & Caviglioli, G. (2020) · Cells · doi:10.3390/cells9122569 · Cited by 100
Toxicity of Zero- and One-Dimensional Carbon Nanomaterials
Raja, I. S., Song, S.-J., Kang, M. S., Lee, Y. B., Kim, B., Hong, S. W., Jeong, S. J., Lee, J.-C., & Han, D. (2019) · Nanomaterials · doi:10.3390/nano9091214 · Cited by 99
Varatharaj, A., Liljeroth, M., Darekar, A., Larsson, H. B. W., Galea, I., & Cramer, S. P. (2018) · The Journal of Physiology · doi:10.1113/jp276887 · Cited by 98
Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier
Hersh, A. M., Bhimreddy, M., Weber-Levine, C., Jiang, K., Alomari, S., Theodore, N., Manbachi, A., & Tyler, B. (2022) · Cancers · doi:10.3390/cancers14194920 · Cited by 98
Ishak, R. A. H., Mostafa, N. M., & Kamel, A. O. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1410263 · Cited by 97
Recent Progress in Microfluidic Models of the Blood-Brain Barrier
Jiang, L., Li, S., Zheng, J., Li, Y., & Huang, H. (2019) · Micromachines · doi:10.3390/mi10060375 · Cited by 96
Huttunen, J., Peltokangas, S., Gynther, M., Natunen, T., Hiltunen, M., Auriola, S., Ruponen, M., Vellonen, K.-S., & Huttunen, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49009-z · Cited by 96
Nano-scale architecture of blood-brain barrier tight-junctions
Sasson, E., Anzi, S., Bell, B., Yakovian, O., Zorsky, M., Deutsch, U., Engelhardt, B., Sherman, E., Vatine, G. D., Dzikowski, R., et al. (2021) · eLife · doi:10.7554/elife.63253 · Cited by 95
Suzuki, K., Miura, Y., Mochida, Y., Miyazaki, T., Toh, K., Anraku, Y., Melo, V., Liu, X., Ishii, T., Nagano, O., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.021 · Cited by 95
de Lima, E. P., Laurindo, L. F., Catharin, V. C. S., Direito, R., Tanaka, M., Jasmin Santos German, I., Lamas, C. B., Guiguer, E. L., Araújo, A. C., Fiorini, A. M. R., et al. (2025) · Metabolites · doi:10.3390/metabo15020124 · Cited by 94
Self-citationChu, C., Jabłońska, A., Gao, Y., Lan, X., Lesniak, W. G., Liang, Y., Liu, G., Li, S., Magnus, T. U., Pearl, M. S., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00634-x · Cited by 93
Bao, X., Wu, J., Xie, Y., Kim, S., Michelhaugh, S., Jiang, J., Mittal, S., Sanai, N., & Li, J. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1710 · Cited by 92
Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
Puris, E., Fricker, G., & Gynther, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03241-x · Cited by 92
Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 92
Lo, K.-J., Wang, M., Ho, C., & Pan, M. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06867 · Cited by 92
Spiridon, I., & Anghel, N. (2025) · Molecules · doi:10.3390/molecules30143044 · Cited by 91
Wang, Y., Ying, X., Xu, H., Yan, H., Li, X., & Tang, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124276 · Cited by 90
Puris, E., Gynther, M., Huttunen, J., Petsalo, A., & Huttunen, K. M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.023 · Cited by 90
Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications
Roveta, F., Bonino, L., Piella, E. M., Rainero, I., & Rubino, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211941 · Cited by 89
Maiuolo, J., Gliozzi, M., Musolino, V., Scicchitano, M., Carresi, C., Scarano, F., Bosco, F., Nucera, S., Ruga, S., Zito, M. C., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092693 · Cited by 89
In vitro blood brain barrier models: An overview
Jagtiani, E., Yeolekar, M., Naik, S., & Patravale, V. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.011 · Cited by 89
Leveraging external data in the design and analysis of clinical trials in neuro-oncology
Rahman, R. M., Ventz, S., McDunn, J., Louv, B., Reyes‐Rivera, I., Polley, M. C., Merchant, F., Abrey, L. E., Allen, J. E., Aguilar, L. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00488-5 · Cited by 88
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)
Chien, H.-C., Colas, C., Finke, K., Springer, S., Stoner, L., Zur, A. A., Venteicher, B., Campbell, J., Hall, C., Flint, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01007 · Cited by 87
From lab to industrial development of lipid nanocarriers using quality by design approach
Buya, A. B., Mahlangu, P., & Witika, B. A. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100266 · Cited by 87
Tanaka, M., Spekker, E., Szabó, Á., Polyák, H., & Vécsei, L. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02513-5 · Cited by 86
Self-citationMolecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
Arguello, A., Mahon, C. S., Calvert, M. E. K., Chan, D., Dugas, J. C., Pizzo, M. E., Thomsen, E. R., Chau, R., Damo, L. A., Duque, J., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211057 · Cited by 86
The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
West, P. K., McCorkindale, A. N., Guennewig, B., Ashhurst, T. M., Viengkhou, B., Hayashida, E., Jung, S. R., Butovsky, O., Campbell, I. L., & Hofer, M. J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02441-x · Cited by 86
Kim, M., Jang, H. Y., Kim, W., Kim, D., & Park, J. H. (2023) · Antioxidants · doi:10.3390/antiox12061286 · Cited by 85
Yang, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17081041 · Cited by 85
Khoury, N., Pizzo, M. E., Discenza, C. B., Joy, D. A., Tatarakis, D., Todorov, M. I., Negwer, M., Ha, C., de Melo, G. L., Sarrafha, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57108-x · Cited by 84
Emerging approaches to polypharmacy among older adults
Mehta, R. S., Kochar, B. D., Kennelty, K. A., Ernst, M. E., & Chan, A. T. (2021) · Nature Aging · doi:10.1038/s43587-021-00045-3 · Cited by 84
Khan, N. U., Ni, J., Ju, X., Miao, T., Chen, H., & Han, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.015 · Cited by 83
An up-to-date overview of computational polypharmacology in modern drug discovery
Chaudhari, R., Fong, L. W., Tan, Z., Huang, B., & Zhang, S. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767063 · Cited by 83
Sánchez-Martínez, J. D., Valdés, A., Gallego, R., Suárez-Montenegro, Z. J., Alarcón, M., Ibáñez, E., Álvarez‐Rivera, G., & Cifuentes, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.924596 · Cited by 83
Tang, B., Zaro, J. L., Shen, Y., Chen, Q., Yu, Y., Sun, P., Wang, Y., Shen, W.-C., Tu, J., & Sun, C. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.016 · Cited by 82
Yamamoto, Y., Välitalo, P. A. J., Wong, Y. C., Huntjens, D. R. H., Proost, J. H., Vermeulen, A., Krauwinkel, W. J. J., Beukers, M. W., Kokki, H. J., Kokki, M., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.011 · Cited by 82
PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
Hoyos-Ceballos, G. P., Ruozi, B., Ottonelli, I., Da Ros, F., Vandelli, M. A., Forni, F., Daini, E., Vilella, A., Zoli, M., Tosi, G., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010072 · Cited by 82
Harnessing the potential of machine learning for advancing “Quality by Design” in biomanufacturing
Walsh, I., Myint, M., Nguyen-Khuong, T., Ho, Y. S., Ng, S. K., & Lakshmanan, M. (2022) · mAbs · doi:10.1080/19420862.2021.2013593 · Cited by 81
Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics
Li, H., Zha, S., Li, H., Liu, H., Wong, K., & All, A. H. (2022) · Small · doi:10.1002/smll.202203629 · Cited by 81
Toader, C., Dumitru, A. V., Eva, L., Șerban, M., Covache-Busuioc, R.-A., & Ciurea, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413302 · Cited by 81
Yanar, F., Carugo, D., & Zhang, X. (2023) · Molecules · doi:10.3390/molecules28155694 · Cited by 80
Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review
Zhang, Y., Lin, X., Chen, X., Fang, W., Yu, K., Gu, W., Wei, Y., Zheng, H., Piao, J., & Li, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s451919 · Cited by 80
Yuan, S., Hu, D., Gao, D., Butch, C. J., Wang, Y., Zheng, H., & Sheng, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03572-y · Cited by 80
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids
Reddy, T. S., Zomer, R., & Mantri, N. L. (2023) · Phytotherapy Research · doi:10.1002/ptr.7742 · Cited by 79
Al-Khazaleh, A. K., Zhou, X., Bhuyan, D. J., Münch, G. W., Al-Dalabeeh, E. A., Jaye, K. M., & Chang, D. (2024) · Molecules · doi:10.3390/molecules29020410 · Cited by 79
The blood-brain barrier studied in vitro across species
Thomsen, M. S., Humle, N., Hede, E., Moos, T., Burkhart, A., & Thomsen, L. B. (2021) · PLOS ONE · doi:10.1371/journal.pone.0236770 · Cited by 79
Wei, Y., Xia, X., Wang, X., Yang, W., He, S., Wang, L., Chen, Y., Zhou, Y., Chen, F., Li, H., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.01.015 · Cited by 78
Shao, M., Jin, X., Chen, S., Yang, N., & Feng, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115904 · Cited by 78
Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid
Hokari, M., Wu, H.-Q., Schwarcz, R., & Smith, Q. R. (1996) · NeuroReport · doi:10.1097/00001756-199612200-00004 · Cited by 78
Hofer, S., Hofstätter, N., Punz, B., Hasenkopf, I., Johnson, L., & Himly, M. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1804 · Cited by 78
Bioavailability of Polyphenols and Flavonoids in the Era of Precision Medicine
Hu, M., Wu, B., & Liu, Z. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00545 · Cited by 78
Park, J. S., Choe, K., Khan, A., Jo, M. H., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065283 · Cited by 78
Feeding Next‐Generation Nanomedicines to Europe: Regulatory and Quality Challenges
Musazzi, U. M., Franzè, S., Condorelli, F., Minghetti, P., & Caliceti, P. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301956 · Cited by 78
Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation
Müller, L., & Di Benedetto, S. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1575022 · Cited by 77
Noumbissi, M. E., Galasso, B., & Stins, M. F. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0097-2 · Cited by 77
Burks, S. R., Kersch, C. N., Witko, J. A., Pagel, M. A., Sundby, M., Muldoon, L. L., Neuwelt, E. A., & Frank, J. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021915118 · Cited by 77
Lehoczki, A., Fekete, M., Jarecsny, T., Zábó, V., Szappanos, Á., Csípő, T., Lipécz, Á., Major, D., Fazekas‐Pongor, V., Varga, P., et al. (2025) · Nutrients · doi:10.3390/nu17172884 · Cited by 77
Transporter-Mediated Drug Delivery
Gyimesi, G., & Hediger, M. A. (2023) · Molecules · doi:10.3390/molecules28031151 · Cited by 77
Kwon, M., Lim, D. Y., Lee, C. H., Jeon, J.-H., Choi, M.-K., & Song, I.-S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090882 · Cited by 76
Laggner, M., Gugerell, A., Bachmann, C., Hofbauer, H., Vorstandlechner, V., Seibold, M., Gouya Lechner, G., Peterbauer, A., Madlener, S., Demyanets, S., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1524-2 · Cited by 76
Isolation of endothelial cells, pericytes and astrocytes from mouse brain
Bernard-Patrzynski, F., Lécuyer, M., Puscas, I., Boukhatem, I., Charabati, M., Bourbonnière, L., Ramassamy, C., Leclair, G., Prat, A., & Roullin, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226302 · Cited by 76
Cascade Drug-Release Strategy for Enhanced Anticancer Therapy
Zhang, X., Wang, S., Cheng, G., Yu, P., Chang, J. K., & Chen, X. S. (2021) · Matter · doi:10.1016/j.matt.2020.10.002 · Cited by 76
Zhu, H., Allwin, C., Bassous, M. G., & Pouliopoulos, A. N. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04795-z · Cited by 75
Applications of Plant-Derived Extracellular Vesicles in Medicine
Zhu, Y., Zhao, J., Ding, H., Qiu, M., Xue, L., Ge, D., Wen, G., Ren, H., Li, P., & Wang, J. (2024) · MedComm · doi:10.1002/mco2.741 · Cited by 75
Drug Delivery Vehicles Based on Albumin–Polymer Conjugates
Jiang, Y., & Stenzel, M. H. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201500453 · Cited by 75
Complement in Hemolysis- and Thrombosis- Related Diseases
Luo, S., Hu, D., Wang, M., Zipfel, P. F., & Hu, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01212 · Cited by 75
Chaulagain, B., Gothwal, A., Lamptey, R. N. L., Trivedi, R., Mahanta, A. K., Layek, B., & Singh, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032710 · Cited by 75
Elsheikh, M. A., Elnaggar, Y. S. R., Hamdy, D. A., & Abdallah, O. Y. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.023 · Cited by 74
Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
Nguyen, T., & Duong, V. (2025) · Pharmaceuticals · doi:10.3390/ph18050615 · Cited by 74
Ionization-Specific Prediction of Blood–Brain Permeability
Lanevskij, K., Japertas, P., Didžiapetris, R., & Petrauskas, A. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21405 · Cited by 74
AI for targeted polypharmacology: The next frontier in drug discovery
Cichońska, A., Ravikumar, B., & Rahman, R. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102771 · Cited by 73
Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
de Lima, E. P., Tanaka, M., Lamas, C. B., Quesada, K., Detregiachi, C. R. P., Araújo, A. C., Guiguer, E. L., Catharin, V. M. C. S., de Castro, M. V. M., Junior, E. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092096 · Cited by 73
Self-citationDrug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 72
Advantages and limitations of nanostructures for biomedical applications
Roszkowski, S., & Durczyńska, Z. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/186846 · Cited by 72
Multi-objective optimization methods in novel drug design
Lambrinidis, G., & Tsantili‐Kakoulidou, A. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1867095 · Cited by 71
Mondello, S., Guedes, V. A., Lai, C., Czeiter, E., Amrein, K., Kobeissy, F., Mechref, Y., Jeromin, A., Mithani, S., Martin, C., et al. (2020) · Cells · doi:10.3390/cells9040977 · Cited by 70
Abdel Hady, M., Sayed, O. M., & Akl, M. A. (2020) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2020.111076 · Cited by 70
Andjelkovic, A. V., Stamatovic, S. M., Phillips, C. M., Martínez-Revollar, G., & Keep, R. F. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00202-7 · Cited by 70
Bae, S., Liu, K., Pouliopoulos, A. N., Ji, R., Jiménez-Gambín, S., Yousefian, O., Kline-Schoder, A. R., Batts, A. J., Tsitsos, F. N., Kokossis, D., et al. (2024) · Theranostics · doi:10.7150/thno.94206 · Cited by 70
AI-Driven Polypharmacology in Small-Molecule Drug Discovery
Abdelsayed, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146996 · Cited by 70
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
Nunes, Y. C., Mendes, N. M., Pereira de Lima, E., Chehadi, A. C., Lamas, C. B., Haber, J. F. S., dos Santos Bueno, M., Araújo, A. C., Catharin, V. C. S., Detregiachi, C. R. P., et al. (2024) · Nutrients · doi:10.3390/nu16162721 · Cited by 69
Self-citationNovell, A., Kamimura, H. A. S., Cafarelli, A., Gerstenmayer, M., Flament, J., Valette, J., Agou, P., Conti, A., Selingue, E., Aron Badin, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66994-8 · Cited by 69
Ohshima, M., Kamei, S., Fushimi, H., Mima, S., Yamada, T., & Yamamoto, T. (2019) · BioResearch open access · doi:10.1089/biores.2019.0026 · Cited by 69
Cannabis and cannabinoids: pharmacology and therapeutic potential
Śmiarowska, M., Białecka, M., & Machoy-Mokrzyńska, A. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0015 · Cited by 69
Grabarczyk, M., Szczepańska, W., Czpakowska, J., Smolińska, E., Szychowska, A., Glabinski, A. R., & Szpakowski, P. (2024) · Antioxidants · doi:10.3390/antiox13111364 · Cited by 69
Bian, X., Guo, Q., Yau, L.-F., Yang, L., Wang, X., Zhao, S., Wu, S., Qin, X., Jiang, Z.-H., & Li, C. (2025) · Nature Communications · doi:10.1038/s41467-025-57488-0 · Cited by 69
Montaser, A. B., Järvinen, J., Löffler, S., Huttunen, J., Auriola, S., Lehtonen, M., Jalkanen, A., & Huttunen, K. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00564 · Cited by 68
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides
Nam, S. H., Park, J., & Koo, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01425-y · Cited by 68
Wong, C. Y. J., Baldelli, A., Hoyos, C. M., Tietz, O., Ong, H. X., & Traini, D. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01558-1 · Cited by 68
Insights into the use of biomarkers in clinical trials in Alzheimer's disease
Pascoal, T. A., Aguzzoli, C. S., Lussier, F. Z., Crivelli, L., Suemoto, C. K., Fortea, J., Rosa‐Neto, P., Zimmer, E. R., Ferreira, P. C. L., & Bellaver, B. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105322 · Cited by 67
Dobrovolskaia, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984252 · Cited by 66
Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment
Luo, S., Lv, Z., Yang, Q., Chang, R., & Wu, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071928 · Cited by 66
Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery
Senanayake, D., Yapa, P. N., Dabare, S., & Munaweera, I. (2025) · RSC Advances · doi:10.1039/d5ra03578c · Cited by 66
Khalil, A., Barras, A., Boukherroub, R., Tseng, C., Devos, D., Burnouf, T., Neuhaus, W., & Szunerits, S. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00306j · Cited by 64
Zheng, Y., Cui, L., Lu, H., Liu, Z., Zhai, Z., Wang, H., Shao, L., Lu, Z., Song, X., & Zhang, Y. X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s497480 · Cited by 64
Recent advances in blood-brain barrier-on-a-chip models
Vetter, J., Palagi, I., Waisman, A., & Blaeser, A. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.03.041 · Cited by 64
Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., et al. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa025 · Cited by 63
Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., & Wang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121611 · Cited by 63
Nabi, A. E., Pouladvand, P., Liu, L., Hua, Y., & Ayubcha, C. (2025) · Molecular Informatics · doi:10.1002/minf.202400325 · Cited by 63
Marton, L. T., Barbalho, S. M., Sloan, K. P., Sloan, L. A., Goulart, R. D. Á., Araújo, A. C., & Bechara, M. D. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1850417 · Cited by 63
Self-citationDing, L., Kshirsagar, P., Agrawal, P., & Murry, D. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060706 · Cited by 62
The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
Buglio, D. S., Marton, L. T., Laurindo, L. F., Guiguer, E. L., Araújo, A. C., Buchaim, R. L., Goulart, R. D. A., Rubira, C. J., & Barbalho, S. M. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0084 · Cited by 62
Self-citationCurrent clinical investigations of focused ultrasound blood-brain barrier disruption: A review
Durham, P. G., Butnariu, A., Alghorazi, R., Pinton, G., Krishna, V., & Dayton, P. A. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00352 · Cited by 62
Xiong, W., Sang, W., Linghu, K. G., Zhong, Z. F., Cheang, W. S., Li, J., Hu, Y. J., Yu, H., & Wang, Y. T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s163763 · Cited by 62
Perspectives About Self-Immolative Drug Delivery Systems
Gonzaga, R. V., do Nascimento, L. A., Santos, S. D. S., Sanches, B. M. A., Giarolla, J., & Ferreira, E. I. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.08.014 · Cited by 62
Xu, Y., Ye, X. W., Du, Y., Yang, W., Tong, F., Li, W., Huang, Q., Chen, Y., Li, H., Gao, H., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.035 · Cited by 62
Wu, Y., & Angelova, A. (2023) · Nanomaterials · doi:10.3390/nano13233004 · Cited by 61
Research developments in the neurovascular unit and the blood‑brain barrier (Review)
Gong, Y., Wu, M., Huang, Y., He, X., Yuan, J., & Dang, B. (2025) · Biomedical Reports · doi:10.3892/br.2025.1966 · Cited by 61
Lipid-Polymer Hybrid Nanoparticles as a Smart Drug Delivery System for Peptide/Protein Delivery
Hassan, A. A. A., Ramadan, E., Kristó, K., Regdon, G., & Sovány, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060797 · Cited by 60
A case report of acute severe paraquat poisoning and long-term follow-up
Yu, G., Kan, B., Jian, X., Wang, J., Sun, J., & Song, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1727 · Cited by 60
Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 59
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312767 · Cited by 58
Self-citationde Lange, E. C. M., van den Brink, W., Yamamoto, Y., de Witte, W. E. A., & Wong, Y. C. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1380623 · Cited by 58
Mohebichamkhorami, F., Faizi, M., Mahmoudifard, M., Hajikarim‐Hamedani, A., Mohseni, S. S., Heidari, A., Ghane, Y., Khoramjouy, M., Khayati, M., Ghasemi, R., et al. (2023) · Small · doi:10.1002/smll.202207626 · Cited by 58
Du, Q., Liu, Y., Fan, M., Wei, S., Ismail, M., & Zheng, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.005 · Cited by 58
Naoi, M., Wu, Y., Maruyama, W., & Shamoto‐Nagai, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072916 · Cited by 58
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
Sanyal, G., Särnefält, A., & Kumar, A. (2021) · npj Vaccines · doi:10.1038/s41541-021-00317-4 · Cited by 57
Ahmed, W., Mushtaq, A., Ali, S., Khan, N., Liang, Y., & Duan, L. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00856 · Cited by 57
Hu, H., Zhou, S., Sun, X., Xue, Y., Yan, L., Sun, X., Lei, M., Li, J., Zeng, X., & Hao, L. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.12.008 · Cited by 57
Carrier-mediated transport to enhance drug delivery to brain
Smith, Q. R. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.012 · Cited by 57
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationAyaz, M., Mosa, O. F., Nawaz, A., Hamdoon, A. A. E., Elkhalifa, M. E. M., Sadiq, A., Ullah, F., Ahmed, A., Kabra, A., Khan, H. Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155272 · Cited by 56
Hidayat, A. F., Wardhana, Y. W., Suwendar, S., Mohammed, A. F. A., Mahmoud, S. A., Elamin, K. M., & Wathoni, N. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s534137 · Cited by 56
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 56
Self-citationQuantitative PET imaging and modeling of molecular blood-brain barrier permeability
Chung, K. J., Abdelhafez, Y. G., Spencer, B. A., Jones, T., Quyen, T. N. T., Nardo, L., Chen, M. S., Sarkar, S., Medici, V., Lyo, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58356-7 · Cited by 56
Liu, Y., Chen, Z., Li, A., Liu, R., Yang, H., & Xia, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.936054 · Cited by 55
Cited by
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Mózes, N., Varga, J. T., Szwajgier, D., Kryczyk‐Poprawa, A., Zábó, V., Lehoczki, A., Lipécz, Á., Csípő, T., Fazekas‐Pongor, V., Major, D., et al. (2026) · Nutrients · doi:10.3390/nu18091470 · Cited by 5
“Certain low-molecular-weight polyphenols, particularly flavonoid aglycones, may cross the BBB via passive diffusion or transporter-mediated mechanisms, although evidence in humans remains limited [139].”
Li, Y., Luo, R., Li, Y., Liu, Z., Duan, X., Qin, S., He, Z., & Liu, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119888 · Cited by 3
Zamani, N. I. S. M., Hamezah, H. S., Mediani, A., Ghazali, M., Sadikan, M. Z., & Jam, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-53311-y · Cited by 2
“To overcome these limitations, nanoparticle-based delivery systems have been widely explored to enhance brain targeting and improve central nervous system (CNS) bioavailability of polyphenolic compounds 51 .”
Dakanalis, A., Papadopoulou, S. Κ., Mentzelou, M., Migdanis, A., Migdanis, I., & Giaginis, C. (2026) · Nutrients · doi:10.3390/nu18142362 · Cited by 3
Uti, D. E., Alum, E. U., Okpe, J. M., Egbung, J. E., & Mbah, J. O. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103524 · Cited by 1
Metadata
- Authors
- Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., & Barbalho, S. M.
- Affiliations
- University of Szeged (HU)
- Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Graduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marilia 17525-902, SP, Brazil
- Corresponding author
- Tanaka, Masaru
- Barbalho, Sandra Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-03-03
- Volume
- 27
- Issue
- 5
- Pages
- 2370
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12985693
- OpenAlex
- W7133487442
- Cited by
- 13
- References
- 654
- Citations by year
- 2026: 13
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- HUN-REN Hungarian Research Network (-)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- blood-brain barrier, polyphenols, prodrugs, phytochemicals, nanocarriers, neurotherapeutics, intranasal drug delivery, focused ultrasound, BBB transporters, tight junctions, brain exposure, drug delivery routes, neuroinflammation, oxidative stress
- MeSH terms
- Animals, Blood-Brain Barrier, Central Nervous System Diseases, Humans, Prodrugs, Drug Delivery Systems, Nanomedicine, Polyphenols
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.